ZA847409B - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- ZA847409B ZA847409B ZA847409A ZA847409A ZA847409B ZA 847409 B ZA847409 B ZA 847409B ZA 847409 A ZA847409 A ZA 847409A ZA 847409 A ZA847409 A ZA 847409A ZA 847409 B ZA847409 B ZA 847409B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/02—Iron compounds
- C07F15/025—Iron compounds without a metal-carbon linkage
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB838325496A GB8325496D0 (en) | 1983-09-23 | 1983-09-23 | Pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA847409B true ZA847409B (en) | 1986-05-28 |
Family
ID=10549201
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA847409A ZA847409B (en) | 1983-09-23 | 1984-09-20 | Pharmaceutical compositions |
Country Status (11)
Country | Link |
---|---|
US (1) | US4587240A (fr) |
EP (1) | EP0138420B1 (fr) |
JP (2) | JPS6094966A (fr) |
CY (1) | CY1574A (fr) |
DE (1) | DE3480599D1 (fr) |
DK (1) | DK161703C (fr) |
GB (2) | GB8325496D0 (fr) |
GR (1) | GR80444B (fr) |
HK (1) | HK7091A (fr) |
SG (1) | SG93290G (fr) |
ZA (1) | ZA847409B (fr) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8308055D0 (en) * | 1983-03-24 | 1983-05-05 | Hider R C | Pharmaceutical compositions |
GB8308054D0 (en) * | 1983-03-24 | 1983-05-05 | Hider R C | Pharmaceutical compositions |
USRE34313E (en) * | 1983-09-23 | 1993-07-13 | National Research Development Corporation | Pharmaceutical compositions |
GB8325496D0 (en) * | 1983-09-23 | 1983-10-26 | Hider R C | Pharmaceutical compositions |
US4912118A (en) * | 1983-09-23 | 1990-03-27 | National Research Development Corporation | Pharmaceutical compositions |
GB8329043D0 (en) * | 1983-10-31 | 1983-11-30 | Hider R C | Pharmaceutical compositions |
US5177068A (en) * | 1984-04-19 | 1993-01-05 | National Research Development Corporation | Pharmaceutical compositions |
US5010191A (en) * | 1985-08-19 | 1991-04-23 | The Regents Of The University Of California | Imaging agents for in vivo magnetic resonance and scintigraphic imaging |
CA1338702C (fr) * | 1987-03-05 | 1996-11-12 | Lawrence D. Mayer | Formulations d'agents liposomiques-antineoplasiques a faible teneur en medicaments-lipides |
MX9203808A (es) * | 1987-03-05 | 1992-07-01 | Liposome Co Inc | Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos. |
US4908371A (en) * | 1987-11-10 | 1990-03-13 | Ciba-Geigy Corporation | Esterified hydroxy dihydropyridinones for treating diseases associated with trivalent metal ion overload |
GB8910521D0 (en) * | 1989-05-08 | 1989-06-21 | Nat Res Dev | The stabilization of organic compounds |
US5443813A (en) * | 1991-06-06 | 1995-08-22 | Associated Universities, Inc. | Loading and conjugating cavity biostructures |
ES2230564T3 (es) | 1995-06-10 | 2005-05-01 | Vitra Pharmaceuticals Ltd. | Compuestos ferricos, composiciones, metodos de fabricacion de estos y sus utilizacioneds. |
US5667933A (en) * | 1996-02-26 | 1997-09-16 | Polaroid Corporation | Image-recording element |
GB9625638D0 (en) * | 1996-12-10 | 1997-01-29 | Cenes Ltd | Therapeutic antioxidants for alzheimer's diease |
ATE556713T1 (de) | 1999-01-13 | 2012-05-15 | Bayer Healthcare Llc | Omega-carboxyarylsubstituierte-diphenyl- harnstoffe als p38-kinasehemmer |
US8124630B2 (en) | 1999-01-13 | 2012-02-28 | Bayer Healthcare Llc | ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
WO2002024196A1 (fr) * | 2000-09-19 | 2002-03-28 | Vitra Pharmaceuticals Limited | Compositions a base de fer |
AU2003209116A1 (en) | 2002-02-11 | 2003-09-04 | Bayer Pharmaceuticals Corporation | Aryl ureas with angiogenesis inhibiting activity |
GB0211500D0 (en) * | 2002-05-18 | 2002-06-26 | Vitra Pharmaceuticals Ltd | Method of forming iron hydroxypyrone compounds |
US7595073B2 (en) * | 2003-02-28 | 2009-09-29 | Kraft Foods Global Brands Llc | Use of siderophores and organic acids to retard lipid oxidation |
US7557129B2 (en) | 2003-02-28 | 2009-07-07 | Bayer Healthcare Llc | Cyanopyridine derivatives useful in the treatment of cancer and other disorders |
JP4860474B2 (ja) | 2003-05-20 | 2012-01-25 | バイエル、ファーマシューテイカルズ、コーポレイション | Pdgfrによって仲介される病気のためのジアリール尿素 |
DK1663978T3 (da) | 2003-07-23 | 2008-04-07 | Bayer Pharmaceuticals Corp | Fluorsubstitueret omega-carboxyaryl-diphenylurinstof til behandling og forebyggelse af sygdomme og lidelser |
CA2627529A1 (fr) | 2007-03-28 | 2008-09-28 | Apotex Technologies Inc. | Derives fluores de deferiprone |
UA102254C2 (ru) | 2008-04-25 | 2013-06-25 | Апотекс Технолоджис Инк. | Жидкий состав для деферипрона с приятным вкусом |
EP2448922B1 (fr) | 2009-07-03 | 2014-08-20 | Apotex Technologies Inc. | Dérivés fluorés de 3-hydroxypyridin-4-ones |
SG183972A1 (en) | 2010-03-23 | 2012-10-30 | Vifor Int Ag | Fe(iii) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias |
BR112013024722B1 (pt) * | 2011-03-29 | 2022-04-12 | Vifor (International) Ag | Medicamento para tratamento e profilaxia de sintomas de deficiência de ferro e anemias por deficiência de ferro |
US20140248342A1 (en) | 2011-05-31 | 2014-09-04 | Vifor (International) Ag | Fe(III) 2,4-Dioxo-1-Carbonyl Complexes For Treatment And Prophylaxis Of Iron Deficiency Symptoms And Iron Deficiency Anaemias |
IN2014DN08294A (fr) * | 2012-04-05 | 2015-05-15 | Vifor Int Ag | |
EP2934508B1 (fr) | 2012-12-21 | 2017-12-06 | Vifor (International) AG | Liaisons de complexes de fe(iii)-2-oxo-butanediamide pour le traitement et la prophylaxie des carences en fer et des anémies |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2748142A (en) * | 1956-05-29 | - process of production | ||
GB778871A (en) * | 1955-02-14 | 1957-07-10 | Sadolin & Holmblad As | Pyridinediol oxides and acetates thereof and their preparation |
GB791719A (en) * | 1955-02-15 | 1958-03-12 | Sadolin & Holmblad As | Improvements in or relating to the production of cyclic hydroxamic acids of the pyridine series |
GB790584A (en) * | 1955-02-15 | 1958-02-12 | Sadolin & Holmblad As | Improvements in or relating to the production of cyclic hydroxamic acids of the pyridine series |
FR3691M (fr) * | 1963-05-06 | 1965-11-15 | Olin Mathieson | Nouvelle composition pharmaceutique utile en tant que fongicide. |
US3968118A (en) * | 1968-08-31 | 1976-07-06 | Hoechst Aktiengesellschaft | Process for the manufacture of 1-hydroxy-2-pyridones |
NL156397B (nl) * | 1968-08-31 | 1978-04-17 | Hoechst Ag | Werkwijze voor het bereiden van preparaten tegen schimmelaandoeningen, gevormde preparaten, alsmede werkwijze voor het bereiden van daarvoor geschikte actieve stoffen. |
US3705943A (en) * | 1969-07-18 | 1972-12-12 | Olin Corp | Dialkyltin salts of substituted pyridine-1-oxides as fungicides and bactericides |
EG10850A (en) * | 1972-03-25 | 1976-06-30 | Hoechst Ag | Process for the preparation of 1-hydroxy-pyridones |
DE2705562A1 (de) * | 1977-02-10 | 1978-08-17 | Basf Ag | Verfahren zur herstellung von pyridonen |
US4358455A (en) * | 1980-12-23 | 1982-11-09 | Merck & Co., Inc. | Aralkylamindethanol heterocyclic compounds |
JPS5832812A (ja) * | 1981-08-21 | 1983-02-25 | Lion Corp | 毛髪化粧料 |
GB2118176B (en) * | 1982-03-24 | 1985-12-04 | Nat Res Dev | Pharmaceutical compositions |
GB2117766B (en) * | 1982-03-24 | 1985-08-29 | Nat Res Dev | Pharmaceutical compositions |
EP0105053B1 (fr) * | 1982-10-01 | 1988-01-20 | Merck & Co. Inc. | Composés hétérocycliques d'aralkylaminoéthanol |
GB8325496D0 (en) * | 1983-09-23 | 1983-10-26 | Hider R C | Pharmaceutical compositions |
US4698431A (en) * | 1985-11-12 | 1987-10-06 | The United States Of America As Represented By The United States Department Of Energy | Hydroxypyridonate chelating agents |
-
1983
- 1983-09-23 GB GB838325496A patent/GB8325496D0/en active Pending
-
1984
- 1984-09-18 US US06/651,772 patent/US4587240A/en not_active Ceased
- 1984-09-20 ZA ZA847409A patent/ZA847409B/xx unknown
- 1984-09-20 EP EP84306437A patent/EP0138420B1/fr not_active Expired
- 1984-09-20 GB GB08423800A patent/GB2146990B/en not_active Expired
- 1984-09-20 DE DE8484306437T patent/DE3480599D1/de not_active Expired - Lifetime
- 1984-09-21 DK DK453584A patent/DK161703C/da not_active IP Right Cessation
- 1984-09-21 GR GR80444A patent/GR80444B/el unknown
- 1984-09-25 JP JP59201407A patent/JPS6094966A/ja active Granted
-
1990
- 1990-11-19 SG SG932/90A patent/SG93290G/en unknown
-
1991
- 1991-01-24 HK HK70/91A patent/HK7091A/xx unknown
- 1991-12-20 CY CY1574A patent/CY1574A/xx unknown
-
1992
- 1992-09-17 JP JP4248272A patent/JPH0811729B2/ja not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
DK161703B (da) | 1991-08-05 |
JPH0811729B2 (ja) | 1996-02-07 |
HK7091A (en) | 1991-02-01 |
DK161703C (da) | 1992-01-20 |
SG93290G (en) | 1991-01-18 |
DE3480599D1 (de) | 1990-01-04 |
JPH0566385B2 (fr) | 1993-09-21 |
JPH05246992A (ja) | 1993-09-24 |
GB2146990B (en) | 1987-05-20 |
GB2146990A (en) | 1985-05-01 |
CY1574A (en) | 1991-12-20 |
DK453584D0 (da) | 1984-09-21 |
EP0138420A3 (en) | 1987-05-20 |
GR80444B (en) | 1985-01-23 |
GB8423800D0 (en) | 1984-10-24 |
EP0138420A2 (fr) | 1985-04-24 |
EP0138420B1 (fr) | 1989-11-29 |
US4587240A (en) | 1986-05-06 |
JPS6094966A (ja) | 1985-05-28 |
DK453584A (da) | 1985-03-24 |
GB8325496D0 (en) | 1983-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2136807B (en) | Pharmaceutical compositions | |
GB8423339D0 (en) | Pharmaceutical compositions | |
GB8403668D0 (en) | Pharmaceutical compositions | |
DE3467703D1 (en) | Pharmaceutical compositions | |
GB8313217D0 (en) | Pharmaceutical compositions | |
ZA847408B (en) | Pharmaceutical compositions | |
GB8415975D0 (en) | Pharmaceutical compositions | |
GB8308126D0 (en) | Pharmaceutical compositions | |
GB8325496D0 (en) | Pharmaceutical compositions | |
CY1678A (en) | Pharmaceutical compositions | |
GB2136806B (en) | Pharmaceutical compositions | |
GB8317595D0 (en) | Pharmaceutical compositions | |
CY1503A (en) | Pharmaceutical compositions | |
GB8412569D0 (en) | Pharmaceutical compositions | |
GB8323553D0 (en) | Pharmaceutical compositions | |
GB8406132D0 (en) | Pharmaceutical compositions | |
GB8419243D0 (en) | Pharmaceutical compositions | |
GB8416358D0 (en) | Pharmaceutical compositions | |
GB8300767D0 (en) | Pharmaceutical compositions | |
GB8305697D0 (en) | Pharmaceutical compositions | |
GB8425250D0 (en) | Pharmaceutical compositions | |
GB2150435B (en) | Pharmaceutical compositions | |
GB8300012D0 (en) | Pharmaceutical compositions | |
GB8317469D0 (en) | Pharmaceutical compositions | |
GB8301718D0 (en) | Pharmaceutical compositions |